Graydon C. Hansen - 11 May 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Signature
/s/ Samuel Gesten as attorney-in-fact for Graydon Hansen
Issuer symbol
STAA
Transactions as of
11 May 2021
Net transactions value
-$1,509,710
Form type
4
Filing time
12 May 2021, 17:03:50 UTC

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $37,779 +1,050 +7.3% $35.98 15,428 11 May 2021 Direct
transaction STAA Common Stock Options Exercise $275,988 +10,025 +65% $27.53 25,453 11 May 2021 Direct
transaction STAA Common Stock Sale $1,236,081 -11,075 -44% $111.61 14,378 11 May 2021 Direct F1
transaction STAA Common Stock Sale $612,503 -5,531 -38% $110.74 8,847 12 May 2021 Direct F2
transaction STAA Common Stock Options Exercise $11,175 +375 +4.2% $29.80 9,222 12 May 2021 Direct
transaction STAA Common Stock Options Exercise $8,311 +231 +2.5% $35.98 9,453 12 May 2021 Direct
transaction STAA Common Stock Options Exercise $5,620 +348 +3.7% $16.15 9,801 12 May 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 -1,050 -13% $0.000000 7,272 11 May 2021 Common Stock 1,050 $35.98 Direct F3
transaction STAA Common Stock Options Options Exercise $0 -10,025 -36% $0.000000 17,737 11 May 2021 Common Stock 10,025 $27.53 Direct F4
transaction STAA Common Stock Options Options Exercise $0 -375 -50% $0.000000 375 12 May 2021 Common Stock 375 $29.80 Direct F5
transaction STAA Common Stock Options Options Exercise $0 -231 -3.2% $0.000000 7,041 12 May 2021 Common Stock 231 $35.98 Direct F3
transaction STAA Common Stock Options Options Exercise $0 -348 -100% $0.000000* 0 12 May 2021 Common Stock 348 $16.15 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.08 to $113.18, inclusive.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $112.29, inclusive.
F3 The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
F4 The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.
F5 The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021.
F6 The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021.